Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
Synapse. 1997 Dec;27(4):294-302. doi: 10.1002/(SICI)1098-2396(199712)27:4<294::AID-SYN3>3.0.CO;2-7.
Synapse. 1997.
PMID: 9372552